Key takeaways

What matters most

  • Oral minoxidil has not shown a clear overall advantage over topical minoxidil across randomized evidence.
  • A newer small trial favored oral treatment, but its topical comparison did not match the current United States label schedule for men.
  • Oral treatment causes more unwanted hair growth, while topical treatment causes more scalp irritation for some people.

Oral minoxidil is not simply stronger or better. A well designed 2024 randomized trial in men did not find oral treatment superior to topical treatment on its main hair density measures after 24 weeks. Blinded photos favored oral treatment at the crown, but not at the frontal scalp.

A smaller 2025 trial of 42 men favored oral treatment. That result matters, but the topical group used treatment less often than the current United States label directs for men. One small study should not erase the larger and more mixed body of evidence.